Hunan Jiudian Pharmaceutical Co., Ltd. announced that its Class 1.1 innovative traditional Chinese medicine, Jiaoqi Pain Relief Gel Patch, has been approved for listing by the National Medical Products Administration. This product offers a new treatment option for patients with knee osteoarthritis caused by cold-dampness and blood stasis. The company will disclose further details upon receiving official documentation.
Summary generated by AI · Always verify with source document
Securities Code: 300705
Bond Code: 123223
Securities Abbreviation: Jiudian Pharmaceutical
Bond Abbreviation: Jiudian Convertible Bond 02
Announcement No.: 2026-037
Hunan Jiudian Pharmaceutical Co., Ltd.
Announcement on the Progress of Drug Registration
The Company and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.